BioSpace News Archive

Policy

Exelixis’ Partner Ipsen Announces EMA Validation of the Application for a New Indication for CABOMETYX® (cabozantinib) for Previously Treated Advanced Hepatocellular Carcinoma

Exelixis, Inc. announced that its partner Ipsen received validation of the application for variation to the CABOMETYX® (cabozantinib) marketing authorization from the European Medicines Agency (EMA) for the addition of a new indication for patients with previously treated advanced hepatocellular carcinoma (HCC).

March 28, 2018
·
9 min read
Business

Evotec AG Fiscal Year 2017 Results: Leading External Innovation

Evotec AG reported financial results and corporate updates for the fiscal year ended 31 December 2017.

March 28, 2018
·
18 min read
Biovica International AB: New Positive Results Support Early Treatment Evaluation of Breast Cancer Using DiviTum

Results from a study of women with metastatic breast cancer demonstrate that DiviTum can provide faster evaluation of treatment efficacy than today’s standard methods and give precise prognosis.

March 28, 2018
·
1 min read
Drug Development

BrainStorm Cell Therapeutics’ Phase 3 Trial of NurOwn® in ALS Now Open to Canadian Patients

Canada-Based ALS Patients Can Be Enrolled at The University of Massachusetts.

March 28, 2018
·
5 min read
Biotech Beach

Human Longevity, Inc. Launches New Health Nucleus Products With Membership Component

HNX And HNX Platinum Offer Clients Comprehensive Health Experience And Follow On Testing.

March 28, 2018
·
2 min read
Pharm Country

Specialized Health Services Stocks’ Research Reports Released on Acadia Healthcare, DaVita, MEDNAX, and Tivity Health

WallStEquities.com strives to bring the best free research to the investment community.

March 28, 2018
·
6 min read
FDA

Haemonetics Announces Regulatory Clearances of NexSys PCS™ Enhanced Software with YES™ Technology

Embedded Software Adds Key Capability to NexSys PCS Platform.

March 28, 2018
·
3 min read
Business

Biscayne Neurotherapeutics Licenses Chinese Rights To Its Novel Antiepileptic Agent To Global Drug Development Centre (GDCC) China

Biscayne Will Provide GDCC Expert Assistance to Speed Development and Marketing of BIS-001ER in China.

March 28, 2018
·
4 min read
Business

ARTMS Appoints Interim CEO and Two New Board Members to Focus on Growth and Global Commercialization

Dr. Kaley Wilson, PhD, appointed the interim Chief Executive Officer.

March 28, 2018
·
3 min read
Drug Development

Walgreens Boots Alliance Reports Fiscal 2018 Second Quarter Results

Walgreens Boots Alliance, Inc. announced financial results for the second quarter of fiscal 2018, which ended 28 February 2018.

March 28, 2018
·
9 min read